Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00754468 · ClinicalTrials.gov registry record · Phase 4
Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.
A Phase 4 study of Esophageal Cancer and Barrett's Esophagus, sponsored by CSA Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00754468 is a Phase 4 study of Esophageal Cancer and Barrett's Esophagus that has completed, run by CSA Medical. The registered enrollment target is 7 participants, below the 499-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00754468, a Phase 4 study of Esophageal Cancer and Barrett's Esophagus, has completed, sponsored by CSA Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the treatment effect, depth of injury, and side effects using technology involving the spray of liquid nitrogen through a catheter (CryoSpray AblationTM, "CSA" or "cryospray therapy") onto healthy tissue via esophagogastroduodenoscopy (EGD) using surgical resection specimens from subjects undergoing esophagectomy.
Conditions Studied
Interventions
- DEVICE Cryo Spray Ablation
Study Locations (1)
Florida
- University of Miami, Sylvester Comprehensive Cancer Center - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00754468
The ClinicalTrials.gov registry entry for NCT00754468 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 499-participant average among 123 other Esophageal Cancer trials with a reported enrollment target (99% lower). The listed sponsor is CSA Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Esophageal Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cryo Spray Ablation is the first listed.
NCT00754468 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT00754468 about?
NCT00754468 is a clinical study titled "Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.". The purpose of this study is to evaluate the treatment effect, depth of injury, and side effects using technology involving the spray of liquid nitrogen through a catheter (CryoSpray AblationTM, "CSA" or "cryospray therapy") onto healthy tissue via esophagogastroduodenoscopy (EGD) using surgical res...
What is the current status of trial NCT00754468?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2009-02. Estimated completion is 2012-03.
What conditions does trial NCT00754468 study?
This clinical trial studies the following conditions: Esophageal Cancer, Barrett's Esophagus.
What interventions are being tested in trial NCT00754468?
The interventions under investigation include: Cryo Spray Ablation (DEVICE).
Who is sponsoring clinical trial NCT00754468?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00754468 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
RECRUITING · Phase 4
-
Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)
RECRUITING · Phase 4
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
Registry for Esophageal and Gastroesophageal Junction Cancer
RECRUITING
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
-
Retrospective Review of Esophageal Cancer at MSKCC
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.